Integragen SA logo

ALINT - Integragen SA Share Price

€1.85 0.0  1.7%

Last Trade - 10:57am

Micro Cap
Market Cap £10.5m
Enterprise Value £7.22m
Revenue £7.66m
Position in Universe 772nd / 847
Unlock ALINT Revenue
Relative Strength (%)
1m -11.3%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -31.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
6.04 5.58 6.02 6.25 6.92 8.28 11.0 13.0 +6.5%
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, IntegraGen SArevenues increased 13% to EUR4.7M. Net income applicable tocommon stockholders totaled EUR17K vs. loss of EUR538K.Revenues reflect France segment increase of 11% to EUR4.4M,Export segment increase of 45% to EUR341K. Net Incomereflects Exceptional Income/Capital increase from EUR226Kto EUR875K (income), Purchases and External Chargesdecrease of 12% to EUR939K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ALINT Revenue Unlock ALINT Revenue

Net Income

ALINT Net Income Unlock ALINT Revenue

Normalised EPS

ALINT Normalised EPS Unlock ALINT Revenue

PE Ratio Range

ALINT PE Ratio Range Unlock ALINT Revenue

Dividend Yield Range

ALINT Dividend Yield Range Unlock ALINT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ALINT EPS Forecasts Unlock ALINT Revenue
Profile Summary

Integragen SA is a France-based company active in the healthcare sector. It researches and develops biomarkers for use as diagnostic tools in the fields of autism, oncology, diabetes and obesity. It uses an evaluation model with several autism-related genes using a combination of several common polymorphisms (Single-Nucleotide Polymorphism or SNP or common variant). It also develops molecular biomarker validation programs for Hepatocellular Carcinoma and anti-epidermal growth factor receptor (anti-EGFR) resistance markers. The Company also provides genomics services to practitioners and researchers, such as DNA extraction, marker selection and tagging and bioinformatical analysis of sequence data in such fields as pharmacogenetics, cytogenetics, epigenetics, search for mutations and SNP discovery, among others. As of December 31, 2011, the Company operated through a wholly owned subsidiary, IntegraGen Inc.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated June 26, 2000
Public Since June 18, 2010
No. of Shareholders: n/a
No. of Employees: 45
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange Euronext - Paris
Shares in Issue 6,628,073
Free Float (0.0%)
Eligible for
ALINT Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ALINT
Upcoming Events for ALINT
Friday 17th September, 2021 Estimate
Integragen SA Annual Shareholders Meeting
Frequently Asked Questions for Integragen SA
What is the Integragen SA share price?

As of 10:57am, shares in Integragen SA are trading at €1.85, giving the company a market capitalisation of £10.5m. This share price information is delayed by 15 minutes.

How has the Integragen SA share price performed this year?

Shares in Integragen SA are currently trading at €1.85 and the price has moved by 21.74% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Integragen SA price has moved by -5.4% over the past year.

What are the analyst and broker recommendations for Integragen SA?

Of the analysts with advisory recommendations for Integragen SA, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Integragen SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Integragen SA next release its financial results?

Integragen SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Integragen SA dividend yield?

Integragen SA does not currently pay a dividend.

Does Integragen SA pay a dividend?

Integragen SA does not currently pay a dividend.

When does Integragen SA next pay dividends?

Integragen SA does not currently pay a dividend.

How do I buy Integragen SA shares?

To buy shares in Integragen SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Integragen SA?

Shares in Integragen SA are currently trading at €1.85, giving the company a market capitalisation of £10.5m.

Where are Integragen SA shares listed? Where are Integragen SA shares listed?

Here are the trading details for Integragen SA:

Country of listing: France
Exchange: PAR
Ticker Symbol: ALINT
What kind of share is Integragen SA?

Based on an overall assessment of its quality, value and momentum, Integragen SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Integragen SA share price forecast 2021?

Shares in Integragen SA are currently priced at €1.85. At that level they are trading at 29.12% discount to the analyst consensus target price of 0.00.

Analysts covering Integragen SA currently have a consensus Earnings Per Share (EPS) forecast of -0.01 for the next financial year.

How can I tell whether the Integragen SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Integragen SA. Over the past six months, the relative strength of its shares against the market has been -35.17%. At the current price of €1.85, shares in Integragen SA are trading at -13.51% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Integragen SA PE Ratio?

The Integragen SA PE ratio based on its reported earnings over the past 12 months is 30.54. The shares are currently trading at €1.85.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Integragen SA?

Integragen SA's management team is headed by:

Bernard Courtieu - CHM
Emmanuel Martin - DSL
Francis Rousseau - OTH
Larry Yost - CEX
Benoit Adelus - DRC
Philippe Boucheron - DRC
Chantal Parpex - DRC
Louis Nisbet - DRC
Francois Liebaert - VRD
Laurence Riot Lamotte - CFO
Cyril Harfouche - DRC
Who are the major shareholders of Integragen SA?

Here are the top five shareholders of Integragen SA based on the size of their shareholding:

Oncodna SA Corporation
Percentage owned: 63.71% (4.27m shares)
IDInvest Partners Venture Capital
Percentage owned: 6.61% (443k shares)
FDE Midcaps AC Mutual Fund
Percentage owned: % (n/a shares)
FDE Patrimoine AC Mutual Fund
Percentage owned: % (n/a shares)
FDE Profil 0-100 Mutual Fund
Percentage owned: % (n/a shares)
Similar to ALINT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.